In LPS-treated active primary mouse astrocytes, rapamycin treatment decreased circHIPK2 expression compared with LPS alone. The authors link this decrease to suppression of astrocytic inflammation through the circHIPK2-SIGMAR1 axis.
Autophagy-mediated circHIPK2 promotes lipopolysaccharide-induced astrocytic inflammation via SIGMAR1.